Global Generic Injectables Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Generic Injectables market size is predicted to grow from US$ 32060 million in 2025 to US$ 39710 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
Generic injectables refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
In the segment of generic sterile injectables, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
LPI (LP Information)' newest research report, the “Generic Injectables Industry Forecast” looks at past sales and reviews total world Generic Injectables sales in 2024, providing a comprehensive analysis by region and market sector of projected Generic Injectables sales for 2025 through 2031. With Generic Injectables sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Injectables industry.
This Insight Report provides a comprehensive analysis of the global Generic Injectables landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Generic Injectables portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Injectables market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Injectables and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Injectables.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Injectables market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Generic Injectables market size is predicted to grow from US$ 32060 million in 2025 to US$ 39710 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
Generic injectables refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
In the segment of generic sterile injectables, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
LPI (LP Information)' newest research report, the “Generic Injectables Industry Forecast” looks at past sales and reviews total world Generic Injectables sales in 2024, providing a comprehensive analysis by region and market sector of projected Generic Injectables sales for 2025 through 2031. With Generic Injectables sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Injectables industry.
This Insight Report provides a comprehensive analysis of the global Generic Injectables landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Generic Injectables portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Injectables market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Injectables and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Injectables.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Injectables market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Small Molecule
- Large Molecule
- Oncology
- Anesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hospira (Pfizer Inc.)
- Fresenius Kabi
- Sandoz (Novartis)
- Hikma Pharmaceuticals PLC
- Dr. Reddy’s Laboratories Ltd
- Grifols
- Nichi-Iko Group (Sagent)
- Teva Pharmaceutical
- Auromedics
- Sanofi
- Gland Pharma
- Endo International PLC
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Injectables Market Size (2020-2031)
2.1.2 Generic Injectables Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Generic Injectables by Country/Region (2020, 2024 & 2031)
2.2 Generic Injectables Segment by Type
2.2.1 Small Molecule
2.2.2 Large Molecule
2.3 Generic Injectables Market Size by Type
2.3.1 Generic Injectables Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Generic Injectables Market Size Market Share by Type (2020-2025)
2.4 Generic Injectables Segment by Application
2.4.1 Oncology
2.4.2 Anesthesia
2.4.3 Anti-Infectives
2.4.4 Parenteral Nutrition
2.4.5 Cardiovascular Diseases
2.5 Generic Injectables Market Size by Application
2.5.1 Generic Injectables Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Generic Injectables Market Size Market Share by Application (2020-2025)
3 GENERIC INJECTABLES MARKET SIZE BY PLAYER
3.1 Generic Injectables Market Size Market Share by Player
3.1.1 Global Generic Injectables Revenue by Player (2020-2025)
3.1.2 Global Generic Injectables Revenue Market Share by Player (2020-2025)
3.2 Global Generic Injectables Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENERIC INJECTABLES BY REGION
4.1 Generic Injectables Market Size by Region (2020-2025)
4.2 Global Generic Injectables Annual Revenue by Country/Region (2020-2025)
4.3 Americas Generic Injectables Market Size Growth (2020-2025)
4.4 APAC Generic Injectables Market Size Growth (2020-2025)
4.5 Europe Generic Injectables Market Size Growth (2020-2025)
4.6 Middle East & Africa Generic Injectables Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Generic Injectables Market Size by Country (2020-2025)
5.2 Americas Generic Injectables Market Size by Type (2020-2025)
5.3 Americas Generic Injectables Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Injectables Market Size by Region (2020-2025)
6.2 APAC Generic Injectables Market Size by Type (2020-2025)
6.3 APAC Generic Injectables Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Injectables Market Size by Country (2020-2025)
7.2 Europe Generic Injectables Market Size by Type (2020-2025)
7.3 Europe Generic Injectables Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Injectables by Region (2020-2025)
8.2 Middle East & Africa Generic Injectables Market Size by Type (2020-2025)
8.3 Middle East & Africa Generic Injectables Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENERIC INJECTABLES MARKET FORECAST
10.1 Global Generic Injectables Forecast by Region (2026-2031)
10.1.1 Global Generic Injectables Forecast by Region (2026-2031)
10.1.2 Americas Generic Injectables Forecast
10.1.3 APAC Generic Injectables Forecast
10.1.4 Europe Generic Injectables Forecast
10.1.5 Middle East & Africa Generic Injectables Forecast
10.2 Americas Generic Injectables Forecast by Country (2026-2031)
10.2.1 United States Market Generic Injectables Forecast
10.2.2 Canada Market Generic Injectables Forecast
10.2.3 Mexico Market Generic Injectables Forecast
10.2.4 Brazil Market Generic Injectables Forecast
10.3 APAC Generic Injectables Forecast by Region (2026-2031)
10.3.1 China Generic Injectables Market Forecast
10.3.2 Japan Market Generic Injectables Forecast
10.3.3 Korea Market Generic Injectables Forecast
10.3.4 Southeast Asia Market Generic Injectables Forecast
10.3.5 India Market Generic Injectables Forecast
10.3.6 Australia Market Generic Injectables Forecast
10.4 Europe Generic Injectables Forecast by Country (2026-2031)
10.4.1 Germany Market Generic Injectables Forecast
10.4.2 France Market Generic Injectables Forecast
10.4.3 UK Market Generic Injectables Forecast
10.4.4 Italy Market Generic Injectables Forecast
10.4.5 Russia Market Generic Injectables Forecast
10.5 Middle East & Africa Generic Injectables Forecast by Region (2026-2031)
10.5.1 Egypt Market Generic Injectables Forecast
10.5.2 South Africa Market Generic Injectables Forecast
10.5.3 Israel Market Generic Injectables Forecast
10.5.4 Turkey Market Generic Injectables Forecast
10.6 Global Generic Injectables Forecast by Type (2026-2031)
10.7 Global Generic Injectables Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Generic Injectables Forecast
11 KEY PLAYERS ANALYSIS
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Information
11.1.2 Hospira (Pfizer Inc.) Generic Injectables Product Offered
11.1.3 Hospira (Pfizer Inc.) Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Hospira (Pfizer Inc.) Main Business Overview
11.1.5 Hospira (Pfizer Inc.) Latest Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Information
11.2.2 Fresenius Kabi Generic Injectables Product Offered
11.2.3 Fresenius Kabi Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Fresenius Kabi Main Business Overview
11.2.5 Fresenius Kabi Latest Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Generic Injectables Product Offered
11.3.3 Sandoz (Novartis) Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sandoz (Novartis) Main Business Overview
11.3.5 Sandoz (Novartis) Latest Developments
11.4 Hikma Pharmaceuticals PLC
11.4.1 Hikma Pharmaceuticals PLC Company Information
11.4.2 Hikma Pharmaceuticals PLC Generic Injectables Product Offered
11.4.3 Hikma Pharmaceuticals PLC Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Hikma Pharmaceuticals PLC Main Business Overview
11.4.5 Hikma Pharmaceuticals PLC Latest Developments
11.5 Dr. Reddy’s Laboratories Ltd
11.5.1 Dr. Reddy’s Laboratories Ltd Company Information
11.5.2 Dr. Reddy’s Laboratories Ltd Generic Injectables Product Offered
11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Dr. Reddy’s Laboratories Ltd Main Business Overview
11.5.5 Dr. Reddy’s Laboratories Ltd Latest Developments
11.6 Grifols
11.6.1 Grifols Company Information
11.6.2 Grifols Generic Injectables Product Offered
11.6.3 Grifols Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Grifols Main Business Overview
11.6.5 Grifols Latest Developments
11.7 Nichi-Iko Group (Sagent)
11.7.1 Nichi-Iko Group (Sagent) Company Information
11.7.2 Nichi-Iko Group (Sagent) Generic Injectables Product Offered
11.7.3 Nichi-Iko Group (Sagent) Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nichi-Iko Group (Sagent) Main Business Overview
11.7.5 Nichi-Iko Group (Sagent) Latest Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Information
11.8.2 Teva Pharmaceutical Generic Injectables Product Offered
11.8.3 Teva Pharmaceutical Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Teva Pharmaceutical Main Business Overview
11.8.5 Teva Pharmaceutical Latest Developments
11.9 Auromedics
11.9.1 Auromedics Company Information
11.9.2 Auromedics Generic Injectables Product Offered
11.9.3 Auromedics Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Auromedics Main Business Overview
11.9.5 Auromedics Latest Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Generic Injectables Product Offered
11.10.3 Sanofi Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sanofi Main Business Overview
11.10.5 Sanofi Latest Developments
11.11 Gland Pharma
11.11.1 Gland Pharma Company Information
11.11.2 Gland Pharma Generic Injectables Product Offered
11.11.3 Gland Pharma Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Gland Pharma Main Business Overview
11.11.5 Gland Pharma Latest Developments
11.12 Endo International PLC
11.12.1 Endo International PLC Company Information
11.12.2 Endo International PLC Generic Injectables Product Offered
11.12.3 Endo International PLC Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Endo International PLC Main Business Overview
11.12.5 Endo International PLC Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Generic Injectables Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Generic Injectables Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Small Molecule
Table 4. Major Players of Large Molecule
Table 5. Generic Injectables Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 7. Global Generic Injectables Market Size Market Share byType (2020-2025)
Table 8. Generic Injectables Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Generic Injectables Market Size Market Share by Application (2020-2025)
Table 11. Global Generic Injectables Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Generic Injectables Revenue Market Share by Player (2020-2025)
Table 13. Generic Injectables Key Players Head office and Products Offered
Table 14. Generic Injectables Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Generic Injectables Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Generic Injectables Market Size Market Share by Region (2020-2025)
Table 19. Global Generic Injectables Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Generic Injectables Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Generic Injectables Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Generic Injectables Market Size Market Share by Country (2020-2025)
Table 23. Americas Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Generic Injectables Market Size Market Share byType (2020-2025)
Table 25. Americas Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Generic Injectables Market Size Market Share by Application (2020-2025)
Table 27. APAC Generic Injectables Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Generic Injectables Market Size Market Share by Region (2020-2025)
Table 29. APAC Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Generic Injectables Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Generic Injectables Market Size Market Share by Country (2020-2025)
Table 33. Europe Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Generic Injectables Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Generic Injectables
Table 39. Key Market Challenges & Risks of Generic Injectables
Table 40. Key IndustryTrends of Generic Injectables
Table 41. Global Generic Injectables Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Generic Injectables Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Generic Injectables Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Generic Injectables Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Hospira (Pfizer Inc.) Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 46. Hospira (Pfizer Inc.) Generic Injectables Product Offered
Table 47. Hospira (Pfizer Inc.) Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Hospira (Pfizer Inc.) Main Business
Table 49. Hospira (Pfizer Inc.) Latest Developments
Table 50.Fresenius Kabi Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 51.Fresenius Kabi Generic Injectables Product Offered
Table 52.Fresenius Kabi Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53.Fresenius Kabi Main Business
Table 54.Fresenius Kabi Latest Developments
Table 55. Sandoz (Novartis) Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 56. Sandoz (Novartis) Generic Injectables Product Offered
Table 57. Sandoz (Novartis) Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sandoz (Novartis) Main Business
Table 59. Sandoz (Novartis) Latest Developments
Table 60. Hikma Pharmaceuticals PLC Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 61. Hikma Pharmaceuticals PLC Generic Injectables Product Offered
Table 62. Hikma Pharmaceuticals PLC Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Hikma Pharmaceuticals PLC Main Business
Table 64. Hikma Pharmaceuticals PLC Latest Developments
Table 65. Dr. Reddy’s Laboratories Ltd Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 66. Dr. Reddy’s Laboratories Ltd Generic Injectables Product Offered
Table 67. Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Dr. Reddy’s Laboratories Ltd Main Business
Table 69. Dr. Reddy’s Laboratories Ltd Latest Developments
Table 70. Grifols Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 71. Grifols Generic Injectables Product Offered
Table 72. Grifols Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Grifols Main Business
Table 74. Grifols Latest Developments
Table 75. Nichi-Iko Group (Sagent) Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 76. Nichi-Iko Group (Sagent) Generic Injectables Product Offered
Table 77. Nichi-Iko Group (Sagent) Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Nichi-Iko Group (Sagent) Main Business
Table 79. Nichi-Iko Group (Sagent) Latest Developments
Table 80.Teva Pharmaceutical Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 81.Teva Pharmaceutical Generic Injectables Product Offered
Table 82.Teva Pharmaceutical Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83.Teva Pharmaceutical Main Business
Table 84.Teva Pharmaceutical Latest Developments
Table 85. Auromedics Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 86. Auromedics Generic Injectables Product Offered
Table 87. Auromedics Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Auromedics Main Business
Table 89. Auromedics Latest Developments
Table 90. Sanofi Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 91. Sanofi Generic Injectables Product Offered
Table 92. Sanofi Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Gland Pharma Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 96. Gland Pharma Generic Injectables Product Offered
Table 97. Gland Pharma Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Gland Pharma Main Business
Table 99. Gland Pharma Latest Developments
Table 100. Endo International PLC Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 101. Endo International PLC Generic Injectables Product Offered
Table 102. Endo International PLC Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Endo International PLC Main Business
Table 104. Endo International PLC Latest Developments
LIST OFFIGURES
Figure 1. Generic Injectables Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Injectables Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Generic Injectables Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Generic Injectables Sales Market Share by Country/Region (2024)
Figure 8. Generic Injectables Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Generic Injectables Market Size Market Share byType in 2024
Figure 10. Generic Injectables in Oncology
Figure 11. Global Generic Injectables Market: Oncology (2020-2025) & ($ millions)
Figure 12. Generic Injectables in Anesthesia
Figure 13. Global Generic Injectables Market: Anesthesia (2020-2025) & ($ millions)
Figure 14. Generic Injectables in Anti-Infectives
Figure 15. Global Generic Injectables Market: Anti-Infectives (2020-2025) & ($ millions)
Figure 16. Generic Injectables in Parenteral Nutrition
Figure 17. Global Generic Injectables Market: Parenteral Nutrition (2020-2025) & ($ millions)
Figure 18. Generic Injectables in Cardiovascular Diseases
Figure 19. Global Generic Injectables Market: Cardiovascular Diseases (2020-2025) & ($ millions)
Figure 20. Global Generic Injectables Market Size Market Share by Application in 2024
Figure 21. Global Generic Injectables Revenue Market Share by Player in 2024
Figure 22. Global Generic Injectables Market Size Market Share by Region (2020-2025)
Figure 23. Americas Generic Injectables Market Size 2020-2025 ($ millions)
Figure 24. APAC Generic Injectables Market Size 2020-2025 ($ millions)
Figure 25. Europe Generic Injectables Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Generic Injectables Market Size 2020-2025 ($ millions)
Figure 27. Americas Generic Injectables Value Market Share by Country in 2024
Figure 28. United States Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Generic Injectables Market Size Market Share by Region in 2024
Figure 33. APAC Generic Injectables Market Size Market Share byType (2020-2025)
Figure 34. APAC Generic Injectables Market Size Market Share by Application (2020-2025)
Figure 35. China Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 39. India Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Generic Injectables Market Size Market Share by Country in 2024
Figure 42. Europe Generic Injectables Market Size Market Share byType (2020-2025)
Figure 43. Europe Generic Injectables Market Size Market Share by Application (2020-2025)
Figure 44. Germany Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 45.France Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Generic Injectables Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Generic Injectables Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Generic Injectables Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Generic Injectables Market Size 2026-2031 ($ millions)
Figure 58. APAC Generic Injectables Market Size 2026-2031 ($ millions)
Figure 59. Europe Generic Injectables Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Generic Injectables Market Size 2026-2031 ($ millions)
Figure 61. United States Generic Injectables Market Size 2026-2031 ($ millions)
Figure 62. Canada Generic Injectables Market Size 2026-2031 ($ millions)
Figure 63. Mexico Generic Injectables Market Size 2026-2031 ($ millions)
Figure 64. Brazil Generic Injectables Market Size 2026-2031 ($ millions)
Figure 65. China Generic Injectables Market Size 2026-2031 ($ millions)
Figure 66. Japan Generic Injectables Market Size 2026-2031 ($ millions)
Figure 67. Korea Generic Injectables Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Generic Injectables Market Size 2026-2031 ($ millions)
Figure 69. India Generic Injectables Market Size 2026-2031 ($ millions)
Figure 70. Australia Generic Injectables Market Size 2026-2031 ($ millions)
Figure 71. Germany Generic Injectables Market Size 2026-2031 ($ millions)
Figure 72.France Generic Injectables Market Size 2026-2031 ($ millions)
Figure 73. UK Generic Injectables Market Size 2026-2031 ($ millions)
Figure 74. Italy Generic Injectables Market Size 2026-2031 ($ millions)
Figure 75. Russia Generic Injectables Market Size 2026-2031 ($ millions)
Figure 76. Egypt Generic Injectables Market Size 2026-2031 ($ millions)
Figure 77. South Africa Generic Injectables Market Size 2026-2031 ($ millions)
Figure 78. Israel Generic Injectables Market Size 2026-2031 ($ millions)
Figure 79.Turkey Generic Injectables Market Size 2026-2031 ($ millions)
Figure 80. Global Generic Injectables Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Generic Injectables Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Generic Injectables Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Injectables Market Size (2020-2031)
2.1.2 Generic Injectables Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Generic Injectables by Country/Region (2020, 2024 & 2031)
2.2 Generic Injectables Segment by Type
2.2.1 Small Molecule
2.2.2 Large Molecule
2.3 Generic Injectables Market Size by Type
2.3.1 Generic Injectables Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Generic Injectables Market Size Market Share by Type (2020-2025)
2.4 Generic Injectables Segment by Application
2.4.1 Oncology
2.4.2 Anesthesia
2.4.3 Anti-Infectives
2.4.4 Parenteral Nutrition
2.4.5 Cardiovascular Diseases
2.5 Generic Injectables Market Size by Application
2.5.1 Generic Injectables Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Generic Injectables Market Size Market Share by Application (2020-2025)
3 GENERIC INJECTABLES MARKET SIZE BY PLAYER
3.1 Generic Injectables Market Size Market Share by Player
3.1.1 Global Generic Injectables Revenue by Player (2020-2025)
3.1.2 Global Generic Injectables Revenue Market Share by Player (2020-2025)
3.2 Global Generic Injectables Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENERIC INJECTABLES BY REGION
4.1 Generic Injectables Market Size by Region (2020-2025)
4.2 Global Generic Injectables Annual Revenue by Country/Region (2020-2025)
4.3 Americas Generic Injectables Market Size Growth (2020-2025)
4.4 APAC Generic Injectables Market Size Growth (2020-2025)
4.5 Europe Generic Injectables Market Size Growth (2020-2025)
4.6 Middle East & Africa Generic Injectables Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Generic Injectables Market Size by Country (2020-2025)
5.2 Americas Generic Injectables Market Size by Type (2020-2025)
5.3 Americas Generic Injectables Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Injectables Market Size by Region (2020-2025)
6.2 APAC Generic Injectables Market Size by Type (2020-2025)
6.3 APAC Generic Injectables Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Injectables Market Size by Country (2020-2025)
7.2 Europe Generic Injectables Market Size by Type (2020-2025)
7.3 Europe Generic Injectables Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Injectables by Region (2020-2025)
8.2 Middle East & Africa Generic Injectables Market Size by Type (2020-2025)
8.3 Middle East & Africa Generic Injectables Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENERIC INJECTABLES MARKET FORECAST
10.1 Global Generic Injectables Forecast by Region (2026-2031)
10.1.1 Global Generic Injectables Forecast by Region (2026-2031)
10.1.2 Americas Generic Injectables Forecast
10.1.3 APAC Generic Injectables Forecast
10.1.4 Europe Generic Injectables Forecast
10.1.5 Middle East & Africa Generic Injectables Forecast
10.2 Americas Generic Injectables Forecast by Country (2026-2031)
10.2.1 United States Market Generic Injectables Forecast
10.2.2 Canada Market Generic Injectables Forecast
10.2.3 Mexico Market Generic Injectables Forecast
10.2.4 Brazil Market Generic Injectables Forecast
10.3 APAC Generic Injectables Forecast by Region (2026-2031)
10.3.1 China Generic Injectables Market Forecast
10.3.2 Japan Market Generic Injectables Forecast
10.3.3 Korea Market Generic Injectables Forecast
10.3.4 Southeast Asia Market Generic Injectables Forecast
10.3.5 India Market Generic Injectables Forecast
10.3.6 Australia Market Generic Injectables Forecast
10.4 Europe Generic Injectables Forecast by Country (2026-2031)
10.4.1 Germany Market Generic Injectables Forecast
10.4.2 France Market Generic Injectables Forecast
10.4.3 UK Market Generic Injectables Forecast
10.4.4 Italy Market Generic Injectables Forecast
10.4.5 Russia Market Generic Injectables Forecast
10.5 Middle East & Africa Generic Injectables Forecast by Region (2026-2031)
10.5.1 Egypt Market Generic Injectables Forecast
10.5.2 South Africa Market Generic Injectables Forecast
10.5.3 Israel Market Generic Injectables Forecast
10.5.4 Turkey Market Generic Injectables Forecast
10.6 Global Generic Injectables Forecast by Type (2026-2031)
10.7 Global Generic Injectables Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Generic Injectables Forecast
11 KEY PLAYERS ANALYSIS
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Information
11.1.2 Hospira (Pfizer Inc.) Generic Injectables Product Offered
11.1.3 Hospira (Pfizer Inc.) Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Hospira (Pfizer Inc.) Main Business Overview
11.1.5 Hospira (Pfizer Inc.) Latest Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Information
11.2.2 Fresenius Kabi Generic Injectables Product Offered
11.2.3 Fresenius Kabi Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Fresenius Kabi Main Business Overview
11.2.5 Fresenius Kabi Latest Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Generic Injectables Product Offered
11.3.3 Sandoz (Novartis) Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sandoz (Novartis) Main Business Overview
11.3.5 Sandoz (Novartis) Latest Developments
11.4 Hikma Pharmaceuticals PLC
11.4.1 Hikma Pharmaceuticals PLC Company Information
11.4.2 Hikma Pharmaceuticals PLC Generic Injectables Product Offered
11.4.3 Hikma Pharmaceuticals PLC Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Hikma Pharmaceuticals PLC Main Business Overview
11.4.5 Hikma Pharmaceuticals PLC Latest Developments
11.5 Dr. Reddy’s Laboratories Ltd
11.5.1 Dr. Reddy’s Laboratories Ltd Company Information
11.5.2 Dr. Reddy’s Laboratories Ltd Generic Injectables Product Offered
11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Dr. Reddy’s Laboratories Ltd Main Business Overview
11.5.5 Dr. Reddy’s Laboratories Ltd Latest Developments
11.6 Grifols
11.6.1 Grifols Company Information
11.6.2 Grifols Generic Injectables Product Offered
11.6.3 Grifols Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Grifols Main Business Overview
11.6.5 Grifols Latest Developments
11.7 Nichi-Iko Group (Sagent)
11.7.1 Nichi-Iko Group (Sagent) Company Information
11.7.2 Nichi-Iko Group (Sagent) Generic Injectables Product Offered
11.7.3 Nichi-Iko Group (Sagent) Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nichi-Iko Group (Sagent) Main Business Overview
11.7.5 Nichi-Iko Group (Sagent) Latest Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Information
11.8.2 Teva Pharmaceutical Generic Injectables Product Offered
11.8.3 Teva Pharmaceutical Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Teva Pharmaceutical Main Business Overview
11.8.5 Teva Pharmaceutical Latest Developments
11.9 Auromedics
11.9.1 Auromedics Company Information
11.9.2 Auromedics Generic Injectables Product Offered
11.9.3 Auromedics Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Auromedics Main Business Overview
11.9.5 Auromedics Latest Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Generic Injectables Product Offered
11.10.3 Sanofi Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sanofi Main Business Overview
11.10.5 Sanofi Latest Developments
11.11 Gland Pharma
11.11.1 Gland Pharma Company Information
11.11.2 Gland Pharma Generic Injectables Product Offered
11.11.3 Gland Pharma Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Gland Pharma Main Business Overview
11.11.5 Gland Pharma Latest Developments
11.12 Endo International PLC
11.12.1 Endo International PLC Company Information
11.12.2 Endo International PLC Generic Injectables Product Offered
11.12.3 Endo International PLC Generic Injectables Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Endo International PLC Main Business Overview
11.12.5 Endo International PLC Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Generic Injectables Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Generic Injectables Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Small Molecule
Table 4. Major Players of Large Molecule
Table 5. Generic Injectables Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 7. Global Generic Injectables Market Size Market Share byType (2020-2025)
Table 8. Generic Injectables Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Generic Injectables Market Size Market Share by Application (2020-2025)
Table 11. Global Generic Injectables Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Generic Injectables Revenue Market Share by Player (2020-2025)
Table 13. Generic Injectables Key Players Head office and Products Offered
Table 14. Generic Injectables Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Generic Injectables Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Generic Injectables Market Size Market Share by Region (2020-2025)
Table 19. Global Generic Injectables Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Generic Injectables Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Generic Injectables Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Generic Injectables Market Size Market Share by Country (2020-2025)
Table 23. Americas Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Generic Injectables Market Size Market Share byType (2020-2025)
Table 25. Americas Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Generic Injectables Market Size Market Share by Application (2020-2025)
Table 27. APAC Generic Injectables Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Generic Injectables Market Size Market Share by Region (2020-2025)
Table 29. APAC Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Generic Injectables Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Generic Injectables Market Size Market Share by Country (2020-2025)
Table 33. Europe Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Generic Injectables Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Generic Injectables Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Generic Injectables Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Generic Injectables
Table 39. Key Market Challenges & Risks of Generic Injectables
Table 40. Key IndustryTrends of Generic Injectables
Table 41. Global Generic Injectables Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Generic Injectables Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Generic Injectables Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Generic Injectables Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Hospira (Pfizer Inc.) Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 46. Hospira (Pfizer Inc.) Generic Injectables Product Offered
Table 47. Hospira (Pfizer Inc.) Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Hospira (Pfizer Inc.) Main Business
Table 49. Hospira (Pfizer Inc.) Latest Developments
Table 50.Fresenius Kabi Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 51.Fresenius Kabi Generic Injectables Product Offered
Table 52.Fresenius Kabi Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53.Fresenius Kabi Main Business
Table 54.Fresenius Kabi Latest Developments
Table 55. Sandoz (Novartis) Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 56. Sandoz (Novartis) Generic Injectables Product Offered
Table 57. Sandoz (Novartis) Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sandoz (Novartis) Main Business
Table 59. Sandoz (Novartis) Latest Developments
Table 60. Hikma Pharmaceuticals PLC Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 61. Hikma Pharmaceuticals PLC Generic Injectables Product Offered
Table 62. Hikma Pharmaceuticals PLC Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Hikma Pharmaceuticals PLC Main Business
Table 64. Hikma Pharmaceuticals PLC Latest Developments
Table 65. Dr. Reddy’s Laboratories Ltd Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 66. Dr. Reddy’s Laboratories Ltd Generic Injectables Product Offered
Table 67. Dr. Reddy’s Laboratories Ltd Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Dr. Reddy’s Laboratories Ltd Main Business
Table 69. Dr. Reddy’s Laboratories Ltd Latest Developments
Table 70. Grifols Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 71. Grifols Generic Injectables Product Offered
Table 72. Grifols Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Grifols Main Business
Table 74. Grifols Latest Developments
Table 75. Nichi-Iko Group (Sagent) Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 76. Nichi-Iko Group (Sagent) Generic Injectables Product Offered
Table 77. Nichi-Iko Group (Sagent) Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Nichi-Iko Group (Sagent) Main Business
Table 79. Nichi-Iko Group (Sagent) Latest Developments
Table 80.Teva Pharmaceutical Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 81.Teva Pharmaceutical Generic Injectables Product Offered
Table 82.Teva Pharmaceutical Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83.Teva Pharmaceutical Main Business
Table 84.Teva Pharmaceutical Latest Developments
Table 85. Auromedics Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 86. Auromedics Generic Injectables Product Offered
Table 87. Auromedics Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Auromedics Main Business
Table 89. Auromedics Latest Developments
Table 90. Sanofi Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 91. Sanofi Generic Injectables Product Offered
Table 92. Sanofi Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Gland Pharma Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 96. Gland Pharma Generic Injectables Product Offered
Table 97. Gland Pharma Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Gland Pharma Main Business
Table 99. Gland Pharma Latest Developments
Table 100. Endo International PLC Details, CompanyType, Generic Injectables Area Served and Its Competitors
Table 101. Endo International PLC Generic Injectables Product Offered
Table 102. Endo International PLC Generic Injectables Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Endo International PLC Main Business
Table 104. Endo International PLC Latest Developments
LIST OFFIGURES
Figure 1. Generic Injectables Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Injectables Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Generic Injectables Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Generic Injectables Sales Market Share by Country/Region (2024)
Figure 8. Generic Injectables Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Generic Injectables Market Size Market Share byType in 2024
Figure 10. Generic Injectables in Oncology
Figure 11. Global Generic Injectables Market: Oncology (2020-2025) & ($ millions)
Figure 12. Generic Injectables in Anesthesia
Figure 13. Global Generic Injectables Market: Anesthesia (2020-2025) & ($ millions)
Figure 14. Generic Injectables in Anti-Infectives
Figure 15. Global Generic Injectables Market: Anti-Infectives (2020-2025) & ($ millions)
Figure 16. Generic Injectables in Parenteral Nutrition
Figure 17. Global Generic Injectables Market: Parenteral Nutrition (2020-2025) & ($ millions)
Figure 18. Generic Injectables in Cardiovascular Diseases
Figure 19. Global Generic Injectables Market: Cardiovascular Diseases (2020-2025) & ($ millions)
Figure 20. Global Generic Injectables Market Size Market Share by Application in 2024
Figure 21. Global Generic Injectables Revenue Market Share by Player in 2024
Figure 22. Global Generic Injectables Market Size Market Share by Region (2020-2025)
Figure 23. Americas Generic Injectables Market Size 2020-2025 ($ millions)
Figure 24. APAC Generic Injectables Market Size 2020-2025 ($ millions)
Figure 25. Europe Generic Injectables Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Generic Injectables Market Size 2020-2025 ($ millions)
Figure 27. Americas Generic Injectables Value Market Share by Country in 2024
Figure 28. United States Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Generic Injectables Market Size Market Share by Region in 2024
Figure 33. APAC Generic Injectables Market Size Market Share byType (2020-2025)
Figure 34. APAC Generic Injectables Market Size Market Share by Application (2020-2025)
Figure 35. China Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 39. India Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Generic Injectables Market Size Market Share by Country in 2024
Figure 42. Europe Generic Injectables Market Size Market Share byType (2020-2025)
Figure 43. Europe Generic Injectables Market Size Market Share by Application (2020-2025)
Figure 44. Germany Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 45.France Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Generic Injectables Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Generic Injectables Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Generic Injectables Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Generic Injectables Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Generic Injectables Market Size 2026-2031 ($ millions)
Figure 58. APAC Generic Injectables Market Size 2026-2031 ($ millions)
Figure 59. Europe Generic Injectables Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Generic Injectables Market Size 2026-2031 ($ millions)
Figure 61. United States Generic Injectables Market Size 2026-2031 ($ millions)
Figure 62. Canada Generic Injectables Market Size 2026-2031 ($ millions)
Figure 63. Mexico Generic Injectables Market Size 2026-2031 ($ millions)
Figure 64. Brazil Generic Injectables Market Size 2026-2031 ($ millions)
Figure 65. China Generic Injectables Market Size 2026-2031 ($ millions)
Figure 66. Japan Generic Injectables Market Size 2026-2031 ($ millions)
Figure 67. Korea Generic Injectables Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Generic Injectables Market Size 2026-2031 ($ millions)
Figure 69. India Generic Injectables Market Size 2026-2031 ($ millions)
Figure 70. Australia Generic Injectables Market Size 2026-2031 ($ millions)
Figure 71. Germany Generic Injectables Market Size 2026-2031 ($ millions)
Figure 72.France Generic Injectables Market Size 2026-2031 ($ millions)
Figure 73. UK Generic Injectables Market Size 2026-2031 ($ millions)
Figure 74. Italy Generic Injectables Market Size 2026-2031 ($ millions)
Figure 75. Russia Generic Injectables Market Size 2026-2031 ($ millions)
Figure 76. Egypt Generic Injectables Market Size 2026-2031 ($ millions)
Figure 77. South Africa Generic Injectables Market Size 2026-2031 ($ millions)
Figure 78. Israel Generic Injectables Market Size 2026-2031 ($ millions)
Figure 79.Turkey Generic Injectables Market Size 2026-2031 ($ millions)
Figure 80. Global Generic Injectables Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Generic Injectables Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Generic Injectables Market Size 2026-2031 ($ millions)
More Publications
Global Breast Biopsy System Market Growth 2024-2030
US$ 3,660.00
June 2024
92 pages
Global Medical Implants Market Growth 2024-2030
US$ 3,660.00
September 2024
103 pages
Global Isoquinoline Market Growth 2025-2031
US$ 3,660.00
January 2025
87 pages
Global Lithotripsy Laser Market Growth 2023-2029
US$ 3,660.00
February 2023
107 pages
